US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
Related reading
US readies new pharmaceutical tariffs
Levies of 100% on certain medicines would implement threats Trump made last year
NHS to increase medicines spending to avoid threatened Trump tariffs
UK government will make it easier for drugs to be approved for use in order to secure carve-out from import levies
Trump administration announces new tariffs on pharmaceuticals
White House also rolls back levies on some metals in an attempt to simplify duties
Europe races to placate pharma as Donald Trump turns up the pressure
Tariff deals with the US have bought time but investment momentum is elsewhere
EU trims exclusivity window for new drugs
Cheaper generics will be allowed on to market a year earlier to curb costs
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs